Outcome of mild SARS-CoV-2-infected renal transplant recipients managed by supervised home-based self-monitoringArticle Published on 2022-08-012023-07-09 Journal: Infectious diseases now [Category] COVID19(2023년), [키워드] Ambulatory treatment COVID-19 Renal transplant SARS-CoV-2. [DOI] 10.1016/j.idnow.2022.05.007 PMC 바로가기
Early multidrug treatment of SARS-CoV-2 infection (COVID-19) and reduced mortality among nursing home (or outpatient/ambulatory) residentsResearch article Published on 2021-08-012022-10-05 Journal: Medical Hypotheses [Category] SARS, 신약개발, 치료법, 치료제, [키워드] acute COVID-19 acute respiratory syndrome ALF Ambulatory treatment Anti-infective Anti-inflammatory Anticoagulant Antiplatelet agent Antithrombotic Antiviral benefit Care clinical suspicion coronavirus Corticosteroid Corticosteroids COVID-19 Cytokine storm death deaths doctor early treatment elderly Elderly patient endothelial injury helping high-risk patient highest hospital Hospitalization Hydroxychloroquine Hypothesis illness Immunity implication In-hospital Infection initial initiated kidney LTF Lungs morbidity and mortality Mortality natural immunity nine nursing home outbreak outcome Patient patients Population positive post infection Prevent Probability provide pulmonary failure receive reduce reduced reduction in mortality regimen Repurposed drug risk robust SARS-CoV-2 SARS-COV-2 infection sequenced severity sick significantly Spread statistically significant Symptom the disease the patient therapeutic option therapy thrombosis Transmission treat Treatment viral replication with COVID-19 worsening [DOI] 10.1016/j.mehy.2021.110622 [Article Type] Research article
Azithromycin in the Successful Management of COVID-19: A Family Physician’s PerspectiveFamily/General Practice Published on 2021-04-202022-10-31 Journal: Cureus [Category] COVID-19, [키워드] absence acute respiratory syndrome Ambulatory treatment anti-inflammatory properties antibiotic Antiviral antiviral activity Antiviral effect association Asthma Azithromycin bacterial co-infection benefit bronchial epithelial cells Brooklyn Care Clinical diagnosis clinical study Community Compliance Complication coronavirus Coronavirus disease-19 coughing Course COVID-19 COVID-19 disease COVID-19 infection COVID-19 outbreak COVID-19 pandemic COVID-19 progression Critical care death Deterioration discharge disease course Dyspnea Efficacy Epidemiology family FIVE Hospitalization Hydroxychloroquine IMPROVE incidence Infection infection with COVID-19 initial majority management nasal New York City NIH pandemic Patient patient hospitalization patients treated patients with COVID-19 Physicians presenting Prevent primary care pro-inflammatory provided pulmonary complication pulmonary condition Pulmonary function Randomized controlled trial reducing responsible RNA viruses SARS-CoV-2 severity Shortness of breath shown supplemental oxygen supportive therapy Symptom symptom duration Symptoms the patient treat Treatment unique wheezing [DOI] 10.7759/cureus.14574 PMC 바로가기 [Article Type] Family/General Practice
Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19)Review Published on 2020-12-302023-07-13 Journal: Rev Cardiovasc Med [Category] SARS, [키워드] Ambulatory treatment Anti-infective Anti-inflammatory Anticoagulant Antiplatelet agent Antiviral Corticosteroid COVID-19 Hospitalization Mortality SARS-CoV-2 sequenced multidrug therapy. [DOI] 10.31083/j.rcm.2020.04.264 PMC 바로가기 [Article Type] Review
Favipiravir and the Need for Early Ambulatory Treatment of SARS-CoV-2 Infection (COVID-19)Comment Published on 2020-11-172023-07-12 Journal: Antimicrobial Agents and Chemotherapy [Category] SARS, [키워드] Ambulatory treatment Antiviral agents COVID-19 favipiravir. SARS-CoV-2 [DOI] 10.1128/AAC.02017-20 PMC 바로가기 [Article Type] Comment